Biotech Bull Market Opportunities: Away from the madding crowd of compute?
Biotech Bull Market Offers Many Opportunities for Traders and Investors Both of the major biotech ETFS are outperfomng Tech and the S&P 500: BB up 25%, XBI up 29% YTD. Innovation and M&A underlying foundation for market support.Genomics theme: ARKG up 84%. Healthcare services are in...
Biotech Stocks Slip into a Red Screen Day as the Market Hits the Snag of Geopolitical Tensions…Update-1
Update-1 Biotech and healthcare stocks look pretty good right now with many large caps still near their highs even Biogen (BIIB) at $228. The IBB at $209 has recovered from the mid-month sell-off. The XBI has lost momentum down 8% for the month, but should rally into the end of Q4, but we are...
Healthcare Sector Update after a Tough Week, Looking for Gains Ahead in Biotech…Update-1 Genomics stocks soar!
Update-1 SMID biotech movers today-Morgan Stanley Healthcare presentation– from our Focus Trading List: Many of these stocks are in the Cathy Wood managed ETF (ARKG). A green screen day in GENOMICS. We are long all of them. Adaptive Biotechnologies (ADPT) up 7.67% to $27. Cryoport (CYRX)...
Healthcare Stocks Hit A Speed Bump, but most TECH Stocks Roll On
Dow (DIA) is Down 2.3% month to date The XLV was down 2.52% to $167 reflecting the weighting of large cap biophrarma drugs in the ETF, the IBB was down 2.17% to the $207 level. The XLK was up only 0.32% but other tech sectors did better but volatile; SMH up 1.19%.,NVDA down 2%, AMD and DELL...
Choppy Markets Ahead as We Wait for Q3 Earnings and a Grim September…Update-3…sector watch
Update-3 -9/11/26... A lot of changes this week especially healthcare with the XLV down about 4.5% wtd.The S&P 500 held up well down a little over 1% and the NASDAQ -100 (QQQ), down only 0.38% wtd. The XLK was up 0.93% wtd despite all the headline news against data centers and the XLF was...
